Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout
Neurocrine expands into metabolic diseases with $2.9 billion Soleno b…
1 month ago
marketscreener.com
Hyperphagia in Prader-Willi syndrome (PWS). Sponsored by Soleno Therapeutics.
6:19
Hyperphagia in Prader-Willi syndrome (PWS). Sponsored by S…
1 month ago
khou.com
Hyperphagia in Prader-Willi syndrome (PWS). Sponsored by Soleno Therapeutics.
6:16
Hyperphagia in Prader-Willi syndrome (PWS). Sponsored by S…
1 month ago
11alive.com
Neurocrine se expande hacia las enfermedades metabólicas con la adquisición de Soleno por 2,900 millones de dólares
Neurocrine se expande hacia las enfermedades metabólicas con la …
1 month ago
marketscreener.com
Soleno Therapeutics’ Vykat XR received FDA approval for hyperphagia in patients with Prader-Willi syndrome (PWS). Read more at https://buff.ly/1YK8NjX by Ayesha Rashid about the treatment, which is the first FDA-approved therapy specifically targeting hyperphagia in the rare genetic disorder. | Xtalks Webinars
0:30
Soleno Therapeutics’ Vykat XR received FDA approval for hyperp…
27 viewsApr 16, 2025
FacebookXtalks Webinars
Soleno Therapeutics : February 2026 Corporate Presentation
Soleno Therapeutics : February 2026 Corporate Presentation
1 month ago
marketscreener.com
Soleno Therapeutics lance un programme de rachat d'actions de 100 millions de dollars
Soleno Therapeutics lance un programme de rachat d'actions d…
5 months ago
zonebourse.com
Cantor Fitzgerald Reiterates Soleno Therapeutics (SLNO) Overweight …
Sep 1, 2023
nasdaq.com
1:47
Soleno stock skyrockets on FDA drug approval
Mar 27, 2025
Yahoo
Neurocrine förvärvar Soleno Therapeutics och stärker portfölje…
1 month ago
marketscreener.com
5:49
In conversation with Anish Bhatnagar: Navigating the Comple…
79 viewsOct 22, 2024
YouTubeIndo US Organization for Rare Diseases
1:03:22
Return of Results Presentation: Destiny-PWS by Soleno Therapeut…
1.2K viewsOct 13, 2020
YouTubeFoundation For Prader-Willi Research
Soleno Therapeutics Announces Preliminary Financial and Operati…
10 months ago
finanznachrichten.de
Soleno Therapeutics Strengthens Leadership Team with Key Appoin…
Jan 24, 2024
finanznachrichten.de
Market movers: Virgin Galactic, Soleno Therapeutics, Medicus Ph…
4 weeks ago
proactiveinvestors.com
41:33
Exploring Rare Disease Drug Approval w/Soleno Therapeutics …
456 viewsFeb 26, 2024
YouTubeGovExperts
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline f…
4 weeks ago
prnewswire.com
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline f…
1 month ago
accessnewswire.com
Gulf Funds Agree to Back Paramount's Takeover of Warner; …
1 month ago
omny.fm
Solvonis Therapeutics CEO on transformational first half, SVN-00…
7 months ago
proactiveinvestors.co.uk
Solvonis Therapeutics CEO on name change, Awakn acquisition …
Jan 14, 2025
proactiveinvestors.co.uk
Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 b…
2 weeks ago
yahoo.com
Careers : an accessible and specialized team - Soleno
Mar 13, 2025
soleno.com
1:53
Why Smart Money is Rotating Into Healthcare #stocks #investing #an…
365 views1 month ago
YouTubeStocktwits
5:22
Solvonis CEO on US patent win and PTSD drug progress
576 views4 months ago
YouTubeProactive Investors
EV Therapeutics - Extracellular Vesicle-based Immunotherapy
Dec 29, 2020
evtherapeutics.com
Company - Intensity Therapeutics
Feb 10, 2021
intensitytherapeutics.com
Nuo Therapeutics, Inc.: Nuo Therapeutics Announces Exclusiv…
Aug 25, 2022
finanznachrichten.de
11:33
Soleno Presentation | Bringing Global Treatments to Market
196 views11 months ago
YouTubeIPWSO
0:13
Neurocrine Biosciences just announced a $2.9Billion all cash a…
1 week ago
linkedin.com
See more videos
Static thumbnail place holder